A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Trial details
- Registry ID
- NCT07872306
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)NCT07872306 | MSLE | Phase 2 | Not yet recruiting | 2028-12-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |